Why the study?
Dynamic control of PKA is essential for cardiac homeostasis, and dysregulation of PKA signalling is associated with a broad range of heart diseases.
Design
Review
No takes yet. Share an insight, caveat, or question.
PKA-targeted therapies merit preclinical development for cardioprotection; leaves open clinical translation pending selective agents and trials.
Liu et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: